| 000 | 01529 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515183410.0 | ||
| 264 | 0 | _c20100330 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.3816/CGC.2009.n.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSagnak, Levent | |
| 245 | 0 | 0 |
_aPredictive value of urinary interleukin-8 cutoff point for recurrences after transurethral resection plus induction bacillus Calmette-Guérin treatment in non-muscle-invasive bladder tumors. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _cAug 2009 |
||
| 300 |
_aE16-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-8 _xurine |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xurine |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xtherapy |
| 650 | 0 | 4 | _aUrologic Surgical Procedures |
| 700 | 1 | _aErsoy, Hamit | |
| 700 | 1 | _aOzok, Ugur | |
| 700 | 1 | _aSenturk, Bugra | |
| 700 | 1 | _aErcil, Hakan | |
| 700 | 1 | _aBahar, Gul | |
| 700 | 1 | _aOzturk, Evrim | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 7 _gno. 2 _gp. E16-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/CGC.2009.n.016 _zAvailable from publisher's website |
| 999 |
_c19094952 _d19094952 |
||